This study is aimed to evaluate outpatient ketamine infusion within a military chronic neuropathic pain population and its effect on PTSD. Currently, this is a pilot study with 30 participants. Participants will be randomized to (1) a moderate dose ketamine, (2) moderate dose ketamine +Mg, or (3) a magnesium control group. Participants will complete self-reported pain and PTSD questionnaires throughout the \~24-week study period. The outlined strategy will provide evidence for the utility of ketamine in neuropathic pain management and pain associated comorbidities within a military population.
Age range
18 Years – 70 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Defense and Veterans Pain Rating Score (DVPRS)
Timeframe: Up to 32 weeks
Brief Pain Inventory Scale (BPI)
Timeframe: Up to 32 weeks
Life Satisfaction Questionnaire (LiSAT)
Timeframe: Up to 32 weeks
Post-traumatic Stress Disorder Checklist (PCL-5)
Timeframe: Up to 32 weeks
The Patient-Reported Outcomes Measurement Information System (PROMIS 29+2)
Timeframe: Up to 32 weeks
Patient Health Questionnaire-9 (PHQ-9)
Timeframe: Up to 32 weeks
Generalized Anxiety Disorder Scale
Timeframe: Up to 32 weeks